

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Activists protest at the World Trade Organization headquarters in Geneva on June 13, 2022. (Photo: Robin Millard/AFP via Getty Images)
The 12th Ministerial Conference of the World Trade Organization kicked off in Geneva on Sunday amid mounting protests against rich nations' refusal to support a patent waiver for coronavirus vaccines and therapeutics, obstruction that has left billions of people around the world without access as Covid-19 continues to spread and take lives.
While WTO Director-General Ngozi Okonjo-Iweala voiced "cautious optimism" that member countries will ultimately reach an agreement on patents and other key items on the body's agenda, civil society groups warned that the intellectual property text currently on the table represents such a departure from South Africa and India's original proposal that it can't even be called a waiver.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for."
"We are extremely disappointed to see that even after 20 months of deliberations and more than 15 million deaths due to Covid, the negotiations are still eons away from ensuring access to lifesaving Covid medical tools for everyone, everywhere," said Candice Sehoma, advocacy adviser for South Africa at Medecins Sans Frontieres (MSF).
"The draft decision text is based on a problematic text from early May and is substantively different from the real waiver proposal we have been supporting," Sehoma continued. "What we're seeing so far is some limited changes, not real progress."
Upon their arrival in Geneva on Sunday, WTO ministers were greeted with protests demanding that they resist lobbying from the pharmaceutical industry and suspend coronavirus-related patents, a move that proponents say would enable low-income countries to produce their own coronavirus vaccines without fear of legal retribution.
Thus far, Pfizer, Moderna, and other vaccine makers have closely guarded their patents and vaccine recipes, and the governments of wealthy countries have done little to force them to share despite the public funding and technology that made the coronavirus vaccines possible.
Critics argue that far from eliminating patent-related barriers to vaccine production, the current draft text at the WTO would actually create more, further hampering the fight against Covid-19 and undermining efforts to prepare for future pandemics.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for, backed by a global movement of millions," Anna Marriott of People's Vaccine Alliance warned Sunday. "It would be unthinkable for the WTO to do nothing in a pandemic, but entirely unconscionable to agree to a deal that would make a bad situation even worse."
"We are deeply concerned that rich nations are negotiating to protect the interests of pharmaceutical corporations, enabled by a WTO intent on saving its own reputation, whatever the cost to public health," Marriott added.
\u201cProtesters are also outside the WTO's #MC12 itself demanding that the EU, UK, Swiss & US governments stop putting Big Pharma profits ahead of saving lives & ending the pandemic /12-GENEVA\u201d— Trade Justice Education Fund (@Trade Justice Education Fund) 1654515636
On the opening day of the pivotal conference, the representatives of wealthy nations gave little indication that they're prepared to drop their support for the pharmaceutical industry's patent protections, which have allowed a handful of companies to rake in huge profits as large swaths of the globe remain unprotected against Covid-19.
As Swiss lawmaker Stefanie Prezioso put it Sunday, Switzerland and other rich countries are acting as "henchmen for Big Pharma."
During remarks on Sunday, Udo Philipp--Germany's state secretary at the Federal Ministry for Economic Affairs and Climate Action--said the current moment requires a "reliable framework to protect intellectual property rights," not suspend them in the interest of equalizing vaccine access.
Germany, home to Pfizer's vaccine partner BioNTech, has long been one of the chief obstacles to substantive patent waiver talks. Because the WTO operates by consensus, obstruction by just one nation is enough to derail progress.
But Germany hasn't been alone. Despite paying lip service to the need for a patent waiver of some kind, the United States has faced backlash for dragging its feet at recent WTO talks and refusing to pressure holdout allies such as the United Kingdom, Canada, and Switzerland.
U.S. Trade Representative Katherine Tai didn't use the word "waiver" during her comments at the WTO conference Sunday, expressing support for "accommodations to the intellectual property rules for Covid vaccines that can facilitate the global health recovery needed to make possible a robust global economic recovery."
Patent waiver talks have gone virtually nowhere in the year since the Biden administration publicly endorsed a patent waiver, describing it as a necessary step given "the extraordinary circumstances of the Covid-19 pandemic."
Sehoma of MSF argued in a statement that while "it is not yet too late to agree on a real waiver over the coming days," it is "imperative that governments stand strong against the inclusion of problematic provisions and strive for an agreement that adequately overcomes intellectual property and restrictive pharmaceutical corporation licensing so that countries can be more self-reliant in providing all Covid medical tools to their people, which is the intention of the original TRIPS waiver proposal."
"If governments agree on an outcome text that fails to include all essential medical tools, all countries, and all major intellectual property issues," said Sehoma, "then it will be both a failure to ensure that people have access to lifesaving medicines, vaccines, and diagnostic tests during this pandemic, and will set a deadly precedent for future global health crises."
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
The 12th Ministerial Conference of the World Trade Organization kicked off in Geneva on Sunday amid mounting protests against rich nations' refusal to support a patent waiver for coronavirus vaccines and therapeutics, obstruction that has left billions of people around the world without access as Covid-19 continues to spread and take lives.
While WTO Director-General Ngozi Okonjo-Iweala voiced "cautious optimism" that member countries will ultimately reach an agreement on patents and other key items on the body's agenda, civil society groups warned that the intellectual property text currently on the table represents such a departure from South Africa and India's original proposal that it can't even be called a waiver.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for."
"We are extremely disappointed to see that even after 20 months of deliberations and more than 15 million deaths due to Covid, the negotiations are still eons away from ensuring access to lifesaving Covid medical tools for everyone, everywhere," said Candice Sehoma, advocacy adviser for South Africa at Medecins Sans Frontieres (MSF).
"The draft decision text is based on a problematic text from early May and is substantively different from the real waiver proposal we have been supporting," Sehoma continued. "What we're seeing so far is some limited changes, not real progress."
Upon their arrival in Geneva on Sunday, WTO ministers were greeted with protests demanding that they resist lobbying from the pharmaceutical industry and suspend coronavirus-related patents, a move that proponents say would enable low-income countries to produce their own coronavirus vaccines without fear of legal retribution.
Thus far, Pfizer, Moderna, and other vaccine makers have closely guarded their patents and vaccine recipes, and the governments of wealthy countries have done little to force them to share despite the public funding and technology that made the coronavirus vaccines possible.
Critics argue that far from eliminating patent-related barriers to vaccine production, the current draft text at the WTO would actually create more, further hampering the fight against Covid-19 and undermining efforts to prepare for future pandemics.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for, backed by a global movement of millions," Anna Marriott of People's Vaccine Alliance warned Sunday. "It would be unthinkable for the WTO to do nothing in a pandemic, but entirely unconscionable to agree to a deal that would make a bad situation even worse."
"We are deeply concerned that rich nations are negotiating to protect the interests of pharmaceutical corporations, enabled by a WTO intent on saving its own reputation, whatever the cost to public health," Marriott added.
\u201cProtesters are also outside the WTO's #MC12 itself demanding that the EU, UK, Swiss & US governments stop putting Big Pharma profits ahead of saving lives & ending the pandemic /12-GENEVA\u201d— Trade Justice Education Fund (@Trade Justice Education Fund) 1654515636
On the opening day of the pivotal conference, the representatives of wealthy nations gave little indication that they're prepared to drop their support for the pharmaceutical industry's patent protections, which have allowed a handful of companies to rake in huge profits as large swaths of the globe remain unprotected against Covid-19.
As Swiss lawmaker Stefanie Prezioso put it Sunday, Switzerland and other rich countries are acting as "henchmen for Big Pharma."
During remarks on Sunday, Udo Philipp--Germany's state secretary at the Federal Ministry for Economic Affairs and Climate Action--said the current moment requires a "reliable framework to protect intellectual property rights," not suspend them in the interest of equalizing vaccine access.
Germany, home to Pfizer's vaccine partner BioNTech, has long been one of the chief obstacles to substantive patent waiver talks. Because the WTO operates by consensus, obstruction by just one nation is enough to derail progress.
But Germany hasn't been alone. Despite paying lip service to the need for a patent waiver of some kind, the United States has faced backlash for dragging its feet at recent WTO talks and refusing to pressure holdout allies such as the United Kingdom, Canada, and Switzerland.
U.S. Trade Representative Katherine Tai didn't use the word "waiver" during her comments at the WTO conference Sunday, expressing support for "accommodations to the intellectual property rules for Covid vaccines that can facilitate the global health recovery needed to make possible a robust global economic recovery."
Patent waiver talks have gone virtually nowhere in the year since the Biden administration publicly endorsed a patent waiver, describing it as a necessary step given "the extraordinary circumstances of the Covid-19 pandemic."
Sehoma of MSF argued in a statement that while "it is not yet too late to agree on a real waiver over the coming days," it is "imperative that governments stand strong against the inclusion of problematic provisions and strive for an agreement that adequately overcomes intellectual property and restrictive pharmaceutical corporation licensing so that countries can be more self-reliant in providing all Covid medical tools to their people, which is the intention of the original TRIPS waiver proposal."
"If governments agree on an outcome text that fails to include all essential medical tools, all countries, and all major intellectual property issues," said Sehoma, "then it will be both a failure to ensure that people have access to lifesaving medicines, vaccines, and diagnostic tests during this pandemic, and will set a deadly precedent for future global health crises."
The 12th Ministerial Conference of the World Trade Organization kicked off in Geneva on Sunday amid mounting protests against rich nations' refusal to support a patent waiver for coronavirus vaccines and therapeutics, obstruction that has left billions of people around the world without access as Covid-19 continues to spread and take lives.
While WTO Director-General Ngozi Okonjo-Iweala voiced "cautious optimism" that member countries will ultimately reach an agreement on patents and other key items on the body's agenda, civil society groups warned that the intellectual property text currently on the table represents such a departure from South Africa and India's original proposal that it can't even be called a waiver.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for."
"We are extremely disappointed to see that even after 20 months of deliberations and more than 15 million deaths due to Covid, the negotiations are still eons away from ensuring access to lifesaving Covid medical tools for everyone, everywhere," said Candice Sehoma, advocacy adviser for South Africa at Medecins Sans Frontieres (MSF).
"The draft decision text is based on a problematic text from early May and is substantively different from the real waiver proposal we have been supporting," Sehoma continued. "What we're seeing so far is some limited changes, not real progress."
Upon their arrival in Geneva on Sunday, WTO ministers were greeted with protests demanding that they resist lobbying from the pharmaceutical industry and suspend coronavirus-related patents, a move that proponents say would enable low-income countries to produce their own coronavirus vaccines without fear of legal retribution.
Thus far, Pfizer, Moderna, and other vaccine makers have closely guarded their patents and vaccine recipes, and the governments of wealthy countries have done little to force them to share despite the public funding and technology that made the coronavirus vaccines possible.
Critics argue that far from eliminating patent-related barriers to vaccine production, the current draft text at the WTO would actually create more, further hampering the fight against Covid-19 and undermining efforts to prepare for future pandemics.
"The text under negotiation at the WTO is not the TRIPS waiver that more than a hundred developing country governments have been fighting for, backed by a global movement of millions," Anna Marriott of People's Vaccine Alliance warned Sunday. "It would be unthinkable for the WTO to do nothing in a pandemic, but entirely unconscionable to agree to a deal that would make a bad situation even worse."
"We are deeply concerned that rich nations are negotiating to protect the interests of pharmaceutical corporations, enabled by a WTO intent on saving its own reputation, whatever the cost to public health," Marriott added.
\u201cProtesters are also outside the WTO's #MC12 itself demanding that the EU, UK, Swiss & US governments stop putting Big Pharma profits ahead of saving lives & ending the pandemic /12-GENEVA\u201d— Trade Justice Education Fund (@Trade Justice Education Fund) 1654515636
On the opening day of the pivotal conference, the representatives of wealthy nations gave little indication that they're prepared to drop their support for the pharmaceutical industry's patent protections, which have allowed a handful of companies to rake in huge profits as large swaths of the globe remain unprotected against Covid-19.
As Swiss lawmaker Stefanie Prezioso put it Sunday, Switzerland and other rich countries are acting as "henchmen for Big Pharma."
During remarks on Sunday, Udo Philipp--Germany's state secretary at the Federal Ministry for Economic Affairs and Climate Action--said the current moment requires a "reliable framework to protect intellectual property rights," not suspend them in the interest of equalizing vaccine access.
Germany, home to Pfizer's vaccine partner BioNTech, has long been one of the chief obstacles to substantive patent waiver talks. Because the WTO operates by consensus, obstruction by just one nation is enough to derail progress.
But Germany hasn't been alone. Despite paying lip service to the need for a patent waiver of some kind, the United States has faced backlash for dragging its feet at recent WTO talks and refusing to pressure holdout allies such as the United Kingdom, Canada, and Switzerland.
U.S. Trade Representative Katherine Tai didn't use the word "waiver" during her comments at the WTO conference Sunday, expressing support for "accommodations to the intellectual property rules for Covid vaccines that can facilitate the global health recovery needed to make possible a robust global economic recovery."
Patent waiver talks have gone virtually nowhere in the year since the Biden administration publicly endorsed a patent waiver, describing it as a necessary step given "the extraordinary circumstances of the Covid-19 pandemic."
Sehoma of MSF argued in a statement that while "it is not yet too late to agree on a real waiver over the coming days," it is "imperative that governments stand strong against the inclusion of problematic provisions and strive for an agreement that adequately overcomes intellectual property and restrictive pharmaceutical corporation licensing so that countries can be more self-reliant in providing all Covid medical tools to their people, which is the intention of the original TRIPS waiver proposal."
"If governments agree on an outcome text that fails to include all essential medical tools, all countries, and all major intellectual property issues," said Sehoma, "then it will be both a failure to ensure that people have access to lifesaving medicines, vaccines, and diagnostic tests during this pandemic, and will set a deadly precedent for future global health crises."
"How the government reacts will tell us so much about how far down the road to autocracy we are," said one lawyer.
A U.S. judge on Friday ordered the return of a Maryland resident who the Trump administration mistakenly deported to a prison in El Salvador last month, according to The Associated Press.
Prior to issuing the ruling, U.S. District Judge Paula Xinis called the deportation of Kilmar Abrego Garcia "an illegal act."
The judge, an appointee of former President Barack Obama, gave the Trump administration end of the day of the day on Monday to bring him back to the United States.
Supporters outside the courtroom cheered as the judge handed down her order, according to The Washington Post.
Responding to the ruling on social media, U.S. Rep. Pramila Jayapal (D-Wash.) said: "This is a big win. Now Trump must comply with the judge's order."
Immigration lawyer Ava Benach wrote: "The right decision. How the government reacts will tell us so much about how far down the road to autocracy we are."
The right decision. How the government reacts will tell us so much about how far down the road to autocracy we are.
[image or embed]
— avabenach.bsky.social (@avabenach.bsky.social) April 4, 2025 at 3:27 PM
Abrego Garcia was among hundreds of people the administration expelled in mid-March to a notorious megaprison in El Salvador after targeting them for alleged gang ties.
In a court papers filed earlier this week in the U.S. District Court for the District of Maryland, an Immigration and Customs Enforcement (ICE) acting field office director admitted that the removal of Abrego Garcia on March 15 "was an error."
Abrego Garcia was deported despite the fact that in 2019, a U.S. immigration judge ruled that he could not be deported to his native El Salvador because he would likely face gang persecution there.
"Corporations get let off the hook, Musk gets insider information, and the American people get hosed."
The latest U.S. agency in the crosshairs of billionaire Elon Musk's Department of Government Efficiency is reportedly the Federal Trade Commission, an already-understaffed department tasked with preventing monopolistic practices and shielding consumers from corporate abuses.
Axios reported Friday that at least two DOGE staffers "now have offices at" the FTC. According to The Verge, two DOGE members "were spotted" at the agency's building this week and "are now listed in the FTC's internal directory."
The Verge noted that the FTC is "a fairly lean agency with fewer than 1,200 employees," a number that the Trump administration has already cut into with the firing of some of the department's consumer protection and antitrust staff.
At least two of Musk's companies, Tesla and X, have faced scrutiny in recent years from the FTC, which is now under the leadership of Trump appointee Andrew Ferguson, who previously pledged to roll back former chair Lina Khan's anti-monopoly legacy.
Emily Peterson-Cassin, corporate power director at the Demand Progress Education Fund, which referred to the operatives as Musk's "minions," said Friday that "DOGE is yet again raiding a federal watchdog tasked with protecting working Americans from Wall Street and Big Tech."
"The FTC has worked to stop monopolistic mergers that would have led to higher grocery prices and is now gearing up to go to court against Meta's social media monopoly," said Peterson-Cassin. "It's no surprise that at this moment, while the economy is in freefall and fraud is on the rise, DOGE is choosing to raid the federal watchdog that protects everyday Americans and threatens corporate monopolies and grifters."
News of DOGE staffers' infiltration of the FTC came as Trump's sweeping new tariffs continued to cause global economic turmoil and heightened concerns that companies in the U.S. will use the tariffs as a new excuse to jack up prices and pad their bottom lines.
Ferguson pledged in a social media post Thursday that under his leadership, the FTC "will be watching closely" to ensure companies don't view Trump's tariffs "as a green light for price fixing or any other unlawful behavior."
But Trump has hobbled the agency—and prompted yet another legal fight—by firing its two Democratic commissioners, a move that sparked fury and has already impacted the FTC's ability to pursue cases against large corporations.
Peterson-Cassin said Friday that "the only winners" of DOGE's targeting of the FTC "are Trump's billionaire besties like [Meta CEO] Mark Zuckerberg and especially Musk, who now stands to gain access to confidential financial information about every company ever investigated by the FTC, including the auto manufacturers, aerospace firms, internet providers, tech companies, and banks that directly compete with his own companies."
"Corporations get let off the hook, Musk gets insider information, and the American people get hosed," Peterson-Cassin added.
"The president single-handedly wiped out Americans' retirement savings overnight and subjected businesses to intense whiplash with his increasingly erratic and chaotic policies that continue to drive consumer and business uncertainty."
Alarm over U.S. President Donald Trump's tariffs continues to grow, with stocks plummeting and JPMorgan warning that "the risk of recession in the global economy this year is raised to 60%, up from 40%."
After China announced new 34% tariffs on all American goods beginning next week, The Associated Press reported Friday that "the S&P 500 was down 4.8% in afternoon trading, after earlier dropping more than 5%, following its worst day since Covid wrecked the global economy in 2020. The Dow Jones Industrial Average was down 1,719 points, or 4.3%, as of 1:08 p.m. Eastern time, and the Nasdaq composite was 4.9% lower."
Noting the state of Wall Street this week, Groundwork Collaborative executive director Lindsay Owens declared in a Friday statement that "Trump has officially brought the economy to its knees."
"The president single-handedly wiped out Americans' retirement savings overnight and subjected businesses to intense whiplash with his increasingly erratic and chaotic policies that continue to drive consumer and business uncertainty," she said. "To call this an economic downturn is an understatement; Trump is marching us straight into a depression."
Political and economic observers have been publicly wondering for weeks if Trump is intentionally crashing the economy. Further fueling those fears, he ramped up his trade war on Wednesday by announcing a minimum 10% tariff for imports, with higher levies for dozens of countries. Although he claimed those steeper duties are "reciprocal," his math "horrified" economists and has been called "crazy."
Responding in a Thursday note titled, There Will Be Blood, head of global economic research Bruce Kasman and other experts at JPMorgan wrote that "if sustained, this year's ~22%-point tariff increase would be the largest U.S. tax hike since 1968."
"The effect of this tax hike is likely to be magnified—through retaliation, a slide in U.S. business sentiment, and supply chain disruptions," states the note, which came before China's announcement.
As Bloomberg reported:
Several Wall Street firms on Thursday warned of a U.S. recession, with some making it their base case, after... Trump announced major levies on goods imported from countries around the world. Other economists, including those at JPMorgan, said the hit could be big, though they are taking a wait-and-see approach before revising their projections.
The announcement rocked global financial markets, and the S&P 500 suffered its worst day since 2020. Trump, speaking on Air Force One on Thursday afternoon, said he was open to reducing tariffs if trading partners were able to offer something "phenomenal."
"We are not making immediate changes to our forecasts and want to see the initial implementation and negotiation process that takes hold," the JPMorgan note says. "However, we view the full implementation of announced policies as a substantial macroeconomic shock not currently incorporated in our forecasts. We thus emphasize that these policies, if sustained, would likely push the U.S. and possibly global economy into recession this year."
The team also pointed out that the United States is in potential danger no matter how other countries are ultimately impacted, calling a "scenario where rest of world muddles through a U.S. recession possible but less likely than global downturn."
As Common Dreams reported last week, in anticipation of Trump's tariff announcement, Goldman Sachs published a research note projecting that the odds of a recession in the next year are 35%, up from 20%.
Other financial industry research firms that have recently warned of a possible recession include Barclays, BofA Global Research, Deutsche Bank, RBC Capital Markets, and UBS Global Wealth Management, according to Reuters.
"This is a game-changer, not only for the U.S. economy, but for the global economy. Many countries will likely end up in a recession," Olu Sonola, head of U.S. economic research at Fitch Ratings, said in a late Wednesday note about the levies. "You can throw most forecasts out the door, if this tariff rate stays on for an extended period of time."
Experts have made similar comments to the press in the wake of the president's Rose Garden remarks on Wednesday. Time on Friday shared some from Brian Bethune, a Boston College economics professor:
"[Consumers] are not even going to the grocery store and paying more for vegetables because there's none available from Mexico, or going to Whole Foods, for example, and finding the big sections of fresh fruit are being shut down. They haven't really felt the full impact [yet], and they're already saying something isn't right," Bethune says.
However, while some economists... are more cautious in their discussion about a possible recession, Bethune says it's "inevitable." The question, he says, is just how long until it happens and for how long will it occur? He sees Trump's admission of there being " some pain" on the horizon as only proof of the inevitability.
"At least they [the Trump administration] are not pretending that it's not disruptive, but they're basically soft-selling it, reflecting their ignorance about the way business operates," Bethune claims.
Also on Friday, the Bureau of Labor Statistics released the latest U.S. jobs data. Although the unemployment rate rose from 4.1% to 4.2% in March, the economy added 228,000 jobs, which was better than expected.
However, economists warn of what lies ahead. As University of Michican economics professor Betsey Stevenson put it, "Today's jobs report is like looking at your vacation photos after you had a horrible car crash on the way home."